β-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cells

por Yi, Yong Weon, Kang, Hyo Jin, Bae, Edward Jeong, Oh, Seunghoon, Seong, Yeon-Sun, Bae, Insoo
Publicado 2015

Dual inhibition of EGFR and MET induces synthetic lethality in triple-negative breast cancer cells through downregulation of ribosomal protein S6

por YI, YONG WEON, YOU, KYUSIC, BAE, EDWARD JEONG, KWAK, SAHNG-JUNE, SEONG, YEON-SUN, BAE, INSOO
Publicado 2015